Ulrich Yvonne C, Cain Kevin C, Sugg Nancy K, Rivara Frederick P, Rubanowice David M, Thompson Robert S
School of Nursing, University of Washington, Seattle, Washington, USA.
Am J Prev Med. 2003 Jan;24(1):9-15. doi: 10.1016/s0749-3797(02)00577-9.
Information on women with domestic violence (DV) suggests increased healthcare utilization across all levels of care and many diagnoses. In the present ancillary study (1997-2002), derived from a large, group-randomized intervention trial we conducted in a staff-model health maintenance organization (HMO) (1995-1998), we examined total and incremental utilization rates, costs, and patterns for women aged >/=18 years with DV identified through the record reviews conducted for the trial. By the choice of comparison groups used, our present aim was to "bracket" any associated increase in utilization.
We compared visits and costs of medical-record confirmed cases of DV (n =62) to those for women without evidence of DV in the record (n =2287). These two groups were derived from women making visits for any one of four index reasons (injury, chronic pelvic pain, depression, or physical examination) associated with higher risk of DV or higher likelihood of its discussion. We constructed a second comparison group (n =6032) from the general population of enrolled women. We used the Chronic Disease Score to adjust for comorbidity.
After adjusting for comorbidity, we found a 1.6-fold higher rate of all visits (95% confidence interval [CI]=1.4-1.9) and 1.6-fold higher estimated costs (95% CI=1.3-2.0) for abused women compared to non-DV women. The rates were 2.3-fold higher when compared to all enrolled women.
Women with medical-record-documented DV demonstrate a pattern of increased utilization and costs across all levels of care and types of diagnoses. We conclude that being a DV case-patient is associated with between 1.6- and 2.3-fold increases in total utilization and costs.
有关遭受家庭暴力(DV)女性的信息表明,在各级医疗护理及多种诊断中,她们的医疗保健利用率均有所提高。在本次辅助研究(1997 - 2002年)中,该研究源自我们于1995 - 1998年在一家员工模式的健康维护组织(HMO)中进行的一项大型群组随机干预试验,我们通过对该试验进行的记录审查,研究了年龄≥18岁且确诊遭受DV的女性的总利用率、增量利用率、成本及模式。通过所选用的比较组,我们当前的目标是“界定”任何相关的利用率增加情况。
我们将病历确诊的DV病例女性(n = 62)的就诊次数和费用与病历中无DV证据的女性(n = 2287)进行了比较。这两组女性来自因与DV风险较高或讨论可能性较大相关的四个索引原因(受伤、慢性盆腔疼痛、抑郁或体格检查)之一而就诊的女性。我们从登记女性的总体人群中构建了第二个比较组(n = 6032)。我们使用慢性病评分来调整合并症情况。
在调整合并症后,我们发现与未遭受DV的女性相比,受虐女性的所有就诊率高出1.6倍(95%置信区间[CI] = 1.4 - 1.9),估计费用高出1.6倍(95% CI = 1.3 - 2.0)。与所有登记女性相比,这些比率高出2.3倍。
病历记录显示遭受DV的女性在各级医疗护理和诊断类型中均呈现出利用率和成本增加的模式。我们得出结论,作为DV病例患者,总利用率和成本会增加1.6至2.3倍。